Kewaunee Scientific Co. (NASDAQ:KEQU) VP Douglas J. Batdorff Sells 3,470 Shares

Kewaunee Scientific Co. (NASDAQ:KEQU) VP Douglas J. Batdorff sold 3,470 shares of the company’s stock in a transaction that occurred on Monday, December 30th. The stock was sold at an average price of $65.50, for a total value of $227,285.00. Following the transaction, the vice president now owns 5,000 shares in the company, valued at $327,500. This trade represents a 40.97 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Kewaunee Scientific Stock Up 1.3 %

Shares of Kewaunee Scientific stock opened at $62.67 on Friday. Kewaunee Scientific Co. has a 1 year low of $27.00 and a 1 year high of $67.20. The firm has a market cap of $179.99 million, a price-to-earnings ratio of 9.93 and a beta of 0.80. The company has a 50-day moving average of $45.05 and a 200 day moving average of $43.89. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.53 and a quick ratio of 2.00.

Analyst Ratings Changes

Separately, StockNews.com raised Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Wednesday, December 18th.

Institutional Investors Weigh In On Kewaunee Scientific

A number of hedge funds and other institutional investors have recently bought and sold shares of KEQU. Ritholtz Wealth Management bought a new stake in shares of Kewaunee Scientific in the 2nd quarter worth approximately $413,000. Dimensional Fund Advisors LP raised its stake in Kewaunee Scientific by 3.6% during the second quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock valued at $8,378,000 after buying an additional 6,132 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of Kewaunee Scientific by 13.4% in the second quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock worth $4,230,000 after acquiring an additional 10,580 shares during the last quarter. Heron Bay Capital Management purchased a new stake in shares of Kewaunee Scientific in the second quarter worth $252,000. Finally, De Lisle Partners LLP increased its holdings in shares of Kewaunee Scientific by 36.6% during the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after acquiring an additional 11,511 shares in the last quarter. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.